glp-1 agonist treatment information sources Clinical Focus on Agonists in Type 2 Diabetes Mellitus Mapping the effectiveness and risks

Feel lighter and more in control of your life

A recent article by Paggers et al

Mounjaro and Ozempic both help control blood sugar and promote weight loss in people with diabetes

Naturally optimize your appetite, cravings and metabolic efficiency for effortless weight loss without medications

In these cardiovascular safety trials, in secondary or exploratory analyses, GLP-1 receptor agonists were also shown to reduce macro-albuminuria, an accepted surrogate marker for diabetic kidney disease (DKD), a condition that still represents a major unmet medical need

Purpose Chronic kidney disease (CKD) is one of the most common complications of type 2 diabetes (T2D), and CKD-related disability and mortality are increasing despite the recent advances in diabetes management